Tiotropium Respimat® decreases the risk of exacerbations in patients with symptomatic asthma independent of baseline characteristics

R. Perez-Chavira, Huib A M Kerstjens, Donald P Tashkin, Michael Engel, Pierluigi Paggiaro, E. Beck

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdato2014
StatusUdgivet - 2014

Citationsformater